JPRN-jRCT2080221497未知3 期
A clinical study of KW-3357 in patients diagnosed as disseminated intravascular coagulation (DIC) by Japanese Association for Acute Medicine-defined DIC criteria
Kyowa Hakko Kirin Co., Ltd.0 个研究点开始时间: 2011年6月28日最近更新:
试验速览
- 阶段
- 3 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Japanese Association for Acute Medicine-defined DIC criteria score >= 4
- •- Antithrombin activity <= 70%
- •- Written informed consent from patient or guardian
排除标准
- •- Anamnesis or complication of serious drug allergy
- •- Serious liver disorder, such as fulminant hepatitis and decompensated cirrhosis
- •- Pregnant, nursing, or possibly pregnant woman
- •- Possibility for the promotion of bleeding by concomitant use of heparin
研究者
相似试验
未知
3 期
A phase III study of KW-3357JPRN-jRCT2080221496Kyowa Hakko Kirin Co., Ltd.
进行中（未招募）
1 期
An Open-Label Study of CK3773274 for Patients with Symptomatic Hypertrophic Cardiomyopathy (HCM) and Left Ventricular Outflow Tract ObstructioObstructive Hypertrophic Cardiomyopathy (oHCM)MedDRA version: 20.0Level: PTClassification code 10020871Term: Hypertrophic cardiomyopathySystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-003571-17-ITCYTOKINETICS, INC.54
进行中（未招募）
1 期
This study is being performed to collect long-term safety and tolerability data of CK-3773274 on patients with obstructive hypertrophic cardiomyopathy (oHCM).obstructive hypertrophic cardiomyopathy (oHCM)MedDRA version: 20.0Level: PTClassification code 10020871Term: Hypertrophic cardiomyopathySystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-003571-17-ESCytokinetics, Inc.54
进行中（未招募）
1 期
This study is performed to collect long term safety and tolerability of aficamten (CK-3773274) on patients with symptomatic hypertrophic cardiomyopathy (HCM)EUCTR2020-003571-17-HUCytokinetics, Inc.300
尚未招募
2 期
An Open-Label Study of CK-3773274 for Patients with Symptomatic Hypertrophic Cardiomyopathy (HCM).Symptomatic Hypertrophic Cardiomyopathythickened heart muscle10010394NL-OMON51492Cytokinetics, Inc.9